Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells

Molecular and Cellular Biology

Volumn 23, Issue 9, 2003, Pages 3265-3273

  Mihaylova, Valia T ^a   Bindra, Ranjit S ^a   Yuan, Jianling ^a   Campisi, Denise ^a   Narayanan, Latha ^a   Jensen, Ryan ^a   Giordano, Frank ^a   Johnson, Randall S ^b   Rockwell, Sara ^a   Glazer, Peter M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; DIMER; DINUCLEOTIDE; DNA; HISTONE; HISTONE DEACETYLASE INHIBITOR; IRON; MESSENGER RNA; MISMATCH REPAIR PROTEIN PMS2; OXYGEN; PROTEIN; PROTEIN MLH1; PROTEIN MSH6; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER; CANCER CELL CULTURE; CELL HYPOXIA; CHROMOSOME; DEACETYLATION; DINUCLEOTIDE REPEAT; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION; GENETIC STABILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAMMAL CELL; MISMATCH REPAIR; MOUSE; MUTAGENESIS; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; QUANTITATIVE ANALYSIS; REPORTER GENE; RNA ANALYSIS; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION REGULATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BASE PAIR MISMATCH; BETA-GALACTOSIDASE; CARRIER PROTEINS; CELL HYPOXIA; CELLS, CULTURED; DEFEROXAMINE; DINUCLEOTIDE REPEATS; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FIBROBLASTS; GENES, REPORTER; HELA CELLS; HUMANS; HYDROXAMIC ACIDS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IRON CHELATING AGENTS; METHYLATION; MICE; MICE, TRANSGENIC; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

ANIMALIA; MAMMALIA;

EID: 0037404420     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.9.3265-3273.2003     Document Type: Article

References (63)

1. Avila, M. A., M. V. Carretero, E. N. Rodriguez, and J. M. Mato. 1998. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology 114:364-371.
2. Baker, S. M., A. W. Plug, T. A. Prolla, C. E. Bronner, A. C. Harris, X. Yao, D. M. Christie, C. Monell, N. Arnheim, A. Bradley, T. Ashley, and R. M. Liskay. 1996. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat. Genet. 13:336-342.
3. Baylin, S. B., M. Esteller, M. R. Rountree, K. E. Bachman, K. Schuebel, and J. G. Herman. 2001. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10:687-692.
4. Berk, J. L., N. Massoomi, C. Hatch, and R. H. Goldstein. 1999. Hypoxia downregulates tropoelastin gene expression in rat lung fibroblasts by pretranslational mechanisms. Am. J. Physiol. 277:L566-572.
5. Brizel, D. M., S. P. Scully, J. M. Harrelson, L. J. Layfield, J. M. Bean, L. R. Prosnitz, and M. W. Dewhirst. 1996. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:941-943.
6. Bruick, R. K., and S. L. McKnight. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337-1340.
7. Bunn, H. F., and R. O. Poyton. 1996. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76:839-885.
8. Chang, D. K., L. Ricciardiello, A. Goel, C. L. Chang, and C. R. Boland. 2000. Steady-state regulation of the human DNA mismatch repair system. J. Biol. Chem. 275:18424-18431.
9. Chen, R. Z., U. Pettersson, C. Beard, L. Jackson-Grusby, and R. Jaenisch. 1998. DNA hypomethylation leads to elevated mutation rates. Nature 395: 89-93.
10. Chen, S., S. H. Bigner, and P. Modrich. 2001. High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6. Proc. Natl. Acad. Sci. USA 98:13802-13807.
11. Coquelle, A., F. Toledo, S. Stern, A. Bieth, and M. Debatisse. 1998. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 2:259-265.
12. Foster, P. L., and J. Cairns. 1992. Mechanisms of directed mutation. Genetics 131:783-789.
13. Fritzell, J. A., L. Narayanan, S. M. Baker, C. E. Bronner, S. E. Andrew, T. A. Prolla, A. Bradley, F. R. Jirik, R. M. Liskay, and P. M. Glazer. 1997. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. Cancer Res. 57:5143-5147.
14. Goldberg, M. A., S. P. Dunning, and H. F. Bunn. 1988. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242:1412-1415.
15. Gunther, E. J., N. E. Murray, and P. M. Glazer. 1993. High efficiency, restriction-deficient in vitro packaging extracts for bacteriophage lambda DNA using a new E. coli lysogen. Nucleic Acids Res. 21:3903-3904.
16. Herman, J. G., A. Umar, K. Polyak, J. R. Graff, N. Ahuja, J. P. Issa, S. Markowitz, J. K. Willson, S. R. Hamilton, K. W. Kinzler, M. F. Kane, R. D. Kolodner, B. Vogelstein, T. A. Kunkel, and S. B. Baylin. 1998. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 95:6870-6875.
17. Hockel, M., K. Schlenger, B. Aral, M. Mitze, U. Schaffer, and P. Vaupel. 1996. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:4509-4515.
18. Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253:49-53.
19. Ito, E., Y. Yanagisawa, Y. Iwahashi, Y. Suzuki, H. Nagasaki, Y. Akiyama, S. Sugano, Y. Yuasa, and K. Maruyama. 1999. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem. Biophys. Res. Commun. 256:488-494.
20. Ivan, M., K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J. M. Asara, W. S. Lane, and W. G. Kaelin, Jr. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464-468.
21. Jaakkola, P., D. R. Mole, Y. M. Tian, M. I. Wilson, J. Gielbert, S. J. Gaskell, A. Kriegsheim, H. F. Hebestreit, M. Mukherji, C. J. Schofield, P. H. Maxwell, C. W. Pugh, and P. J. Ratcliffe. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472.
22. Kane, M. F., M. Loda, G. M. Gaida, J. Lipman, R. Mishra, H. Goldman, J. M. Jessup, and R. Kolodner. 1997. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:808-811.
23. Kim, M. S., H. J. Kwon, Y. M. Lee, J. H. Baek, J. E. Jang, S. W. Lee, E. J. Moon, H. S. Kim, S. K. Lee, H. Y. Chung, C. W. Kim, and K. W. Kim. 2001. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7:437-443.
24. Kolodner, R. 1996. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10:1433-1442.
25. Koong, A. C., N. C. Denko, K. M. Hudson, C. Schindler, L. Swiersz, C. Koch, S. Evans, H. Ibrahim, Q. T. Le, D. J. Terris, and A. J. Giaccia. 2000. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 60:883-887.
26. Loeb, L. A. 1991. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:3075-3079.
27. Marks, P. A., V. M. Richon, and R. A. Rifkind. 2000. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92:1210-1216.
28. Minchenko, A., S. Salceda, T. Bauer, and J. Caro. 1994. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell. Mol. Biol. Res. 40:35-39.
29. Modrich, P., and R. Lahue. 1996. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65:101-133.
30. Nair, A. R., L. J. Boersma, L. Schiltz, M. A. Chaudhry, R. J. Muschel, and A. Chaudry. 2001. Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA. Cancer Lett. 166:55-64.
31. Narayanan, L., J. A. Fritzell, S. M. Baker, R. M. Liskay, and P. M. Glazer. 1997. Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc. Natl. Acad. Sci. USA 94:3122-3127.
32. Paquette, B., and J. B. Little. 1994. In vivo enhancement of genomic instability in minisatellite sequences of mouse C3H/10T1/2 cells transformed in vitro by X-rays. Cancer Res. 54:3173-3178.
33. Parsons, R., G. M. Li, M. J. Longley, W. H. Fang, N. Papadopoulos, J. Jen, A. de la Chapelle, K. W. Kinzler, B. Vogelstein, and P. Modrich. 1993. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75:1227-1236.
34. Peretz, S., R. Jensen, R. Baserga, and P. M. Glazer. 2001. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc. Natl. Acad. Sci. USA 98:1676-1681.
35. Reisdorph, R., and R. Lindahl. 1998. Hypoxia exerts cell-type-specific effects on expression of the class 3 aldehyde dehydrogenase gene. Biochem. Biophys. Res. Commun. 249:709-712.
36. Reynolds, T. Y., S. Rockwell, and P. M. Glazer. 1996. Genetic instability induced by the tumor microenvironment. Cancer Res. 56:5754-5757.
37. Rice, G. C., C. Hoy, and R. T. Schimke. 1986. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 83:5978-5982.
38. Rockwell, S. 1977. In vivo-in vitro tumor systems: new models for studying the response of tumours to therapy. Lab. Anim. Sci. 27:831-851.
39. Rockwell, S. 1997. Oxygen delivery: implications for the biology and therapy of solid tumors. Oncol. Res. 9:383-390.
40. Rosenberg, S. M. 2001. Evolving responsively: adaptive mutation. Nat. Rev. Genet. 2:504-515.
41. Rountree, M. R., K. E. Bachman, J. G. Herman, and S. B. Baylin. 2001. DNA methylation, chromatin inheritance, and cancer. Oncogene 20:3156-3165.
42. Ryan, H. E., M. Poloni, W. McNulty, D. Elson, M. Gassmann, J. M. Arbeit, and R. S. Johnson. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60:4010-4015.
43. Semenza, G. L. 2000. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharmacol. 59:47-53.
44. Semenza, G. L. 2000. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88:1474-1480.
45. Semenza, G. L. 2001. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107:1-3.
46. Semenza, G. L. 2000. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35:71-103.
47. Sook Kim, M., J. Hyen Baek, M. K. Bae, and K. W. Kim. 2001. Human rad21 gene, hHR21(SP), is downregulated by hypoxia in human tumor cells. Biochem. Biophys. Res. Commun. 281:1106-1112.
48. Strand, M., T. A. Prolla, R. M. Liskay, and T. D. Petes. 1993. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365:274-276. (Erratum, 368:569, 1994.)
49. Sutherland, R. M. 1998. Tumor hypoxia and gene expression - implications for malignant progression and therapy. Acta Oncol. 37:567-574.
50. Wang, G., D. D. Levy, M. M. Seidman, and P. M. Glazer. 1995. Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol. Cell. Biol. 15:1759-1768.
51. Wang, G. L., and G. L. Semenza. 1993. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268:21513-21518.
52. Wang, G. L., and G. L. Semenza. 1993. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:3610-3615.
53. Warren, S. M., D. S. Steinbrech, B. J. Mehrara, P. B. Saadeh, J. A. Greenwald, J. A. Spector, P. J. Bouletreau, and M. T. Longaker. 2001. Hypoxia regulates osteoblast gene expression. J. Surg. Res. 99:147-155.
54. Wilkinson, D., J. K. Sandhu, J. W. Breneman, J. D. Tucker, and H. C. Birnboim. 1995. Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro. Br. J. Cancer 72:1234-1240.
55. Williams, K. J., R. L. Cowen, and I. J. Stratford. 2001. Hypoxia and oxidative stress. Tumour hypoxia - therapeutic considerations. Breast Cancer Res. 3:328-331.
56. Wood, R. D. 1996. DNA repair in eukaryotes. Annu. Rev. Biochem. 65:135-167.
57. Xiong, Z., and P. W. Laird. 1997. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25:2532-2534.
58. Yao, X., A. B. Buermeyer, L. Narayanan, D. Tran, S. M. Baker, T. A. Prolla, P. M. Glazer, R. M. Liskay, and N. Arnheim. 1999. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc. Natl. Acad. Sci. USA 96:6850-6855.
59. Yoshida, M., M. Kijima, M. Akita, and T. Beppu. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:17174-17179.
60. Young, S. D., R. S. Marshall, and R. P. Hill. 1988. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. USA 85:9533-9537.
61. Yuan, J., and P. M. Glazer. 1998. Mutagenesis induced by the tumor microenvironment. Mutat. Res. 400:439-446.
62. Yuan, J., L. Narayanan, S. Rockwell, and P. M. Glazer. 2000. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res. 60:4372-4376.
63. Zhu, H., and H. F. Bunn. 2001. Signal transduction. How do cells sense oxygen? Science 292:449-451.